News

Mabgeek Biotech has obtained the clinical approval for a drug for sinusitis.

2023-12-24 0

Image source: CDE official website

Return to List

PREV 2023-11-09
The phase II data of the long-acting IL-4R antibody for atopic dermatitis from Mabgeek Biotech was presented at bio Europe 2023, attracting much attention.
NEXT 2024-03-11
MG-K10 presented top-line data from its Phase II clinical trial for atopic dermatitis in a poster presentation at the 2024 American Academy of Dermatology Annual Meeting.

About
R&D
- Areas
- Pipeline
- Platforms
Publications
- MG-K10
- MG-ZG122
Careers
- Culture
- Join Us

Contact Us

ADD:No.5, Building 34, Lane 122, Chunxiao Road, Zhangjiang Town, Pudong New Area, Shanghai
TEL: +86-21-51371305
EMAlL:info@mabgeek.com

All Rights Reserved by HUNAN MABGEEK BIOTECH CO., LTD © 2018-2024 mabge.com

湘ICP备2024096314号公安部备案：31011502015815